genetherapy-ophthalmology.com Open in urlscan Pro
5.134.13.35  Public Scan

Form analysis
1 forms found in the DOM

GET https://genetherapy-ophthalmology.com/

<form role="search" method="get" id="searchform" class="searchform" action="https://genetherapy-ophthalmology.com/">
  <div>
    <label class="screen-reader-text" for="s"> Search</label>
    <input type="text" value="" name="s" id="s" placeholder="">
    <input type="submit" id="searchsubmit" value="Search">
  </div>
</form>

Text Content

Skip to content


SEPTEMBER 10-12, 2024
BOSTON, MA

Register by Friday & Save Up to $1,100
Menu

 * Home
 * About
   * About Event
   * Venue
   * Events in the Series
   * Hanson Wade
 * What’s On
   * Full Event Guide
   * Speakers
   * Pre-Conference Workshop Day
   * Day One
   * Day Two
 * Partnership
   * Partnership Opportunities
   * Partnership Prospectus
 * Register
   * Register
   * Contact Us




LEVERAGE GENE ADDITION, SILENCING & EDITING APPROACHES TO REVOLUTIONIZE
DEVELOPMENT & DELIVERY OF GENE THERAPIES TO THE EYE

EVENT GUIDE
REGISTER
PARTNER



WELCOME TO THE 5TH GENE THERAPY FOR OPHTHALMIC DISORDERS SUMMIT

Harness Genetic Medicine for Treatment of Rare & Common Eye Diseases

Ophthalmic drug developers are unlocking the full potential of gene therapy.
Crucial lessons learnt from both clinical successes and failures, coupled with
recent improvements in development and delivery, means that the space is poised
to capitalize on the significant potential of the eye as a target for genetic
medicine approaches.

Join 100+ industry leaders at the 5th Gene Therapy for Ophthalmic Disorders
Summit to uncover cutting-edge gene therapy breakthroughs. Harness the latest
developments in vector engineering to target retinal cells more effectively with
higher transduction efficiency. Understand the crucial role of endpoint
selection to clearly demonstrate product efficacy to the FDA & EMA. Understand
the risk-benefit profiles of different ocular administration routes including
intravitreal, subretinal, and suprachoroidal delivery to choose the best option
for your specific indication. Learn from successful clinical trials as well as
where trials have fallen short of expectations to take forward crucial lessons
learnt on progressing a gene therapy rapidly through the clinic without
compromising on safety.











OUR WORLD-CLASS SPEAKER FACULTY INCLUDES:

ARUN UPADHYAY

Chief Scientific Officer, Head of Research and Development

Ocugen



HEMANT KHANNA

Vice President, Preclinical Ocular Research

Astellas



JEAN CHANG

Vice President, Clinical Operations

Nanoscope Therapeutics Inc.



MARYAM MOKTARZADEH

Senior Director, Regulatory Strategy

REGENXBIO



MELISSA CALTON

Vice President, Early-Stage Product Development

4D Molecular Therapeutics



PETER FRANCIS

Chief Scientific & Medical Officer

Ray Therapeutics



VIEW SPEAKERS




PREVIOUS ATTENDING COMPANIES INCLUDE:







OTHER EVENTS IN THE GENE THERAPY SERIES

www.genetherapy-ophthalmology.com



www.genetherapy-neurological.com



www.genetherapy-muscular.com



www.genetherapy-analytical.com



www.next-gen-genetherapy-vectors.com



www.genetherapy-ophthalmology.com



www.genetherapy-neurological.com



www.genetherapy-muscular.com



www.genetherapy-analytical.com



www.next-gen-genetherapy-vectors.com



www.genetherapy-ophthalmology.com



www.genetherapy-neurological.com



www.genetherapy-muscular.com




EVENT GUIDE
REGISTER
PARTNER


VENUE


WYNDHAM BOSTON BEACON HILL
5 BLOSSOM STREET,
BOSTON, MA 02114,
UNITED STATES


LOCATION




OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com


JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have
opportunities to learn quickly, advance your career, and to meaningfully impact
our customers and our business.

Click here to learn about careers.


ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of
distinctive R&D areas. We deliver insight and connections to facilitate safe and
effective drug development for more personalized and targeted patient
populations.


EXPLORE OUR PRODUCTS

Conferences Beacon Searchlight Intelligence


SEARCH

Search


ORGANIZED BY



Terms & Conditions

Privacy Policy

A Hanson Wade Group Company



© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade
Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If
you continue to use this site we will assume that you are happy with it.Ok
sign up to get CONFERENCE PROGRAM UPDATES
X
X
VIEW THE FULL EVENT GUIDE
ACCESS THE 3-DAY AGENDA, SPEAKER LIST, WORKSHOP DETAILS, AND ATTENDING AUDIENCE





 * 
   United States+1
 * 
   United Kingdom+44
 * 
 * 
   Afghanistan (‫افغانستان‬‎)+93
 * 
   Albania (Shqipëri)+355
 * 
   Algeria (‫الجزائر‬‎)+213
 * 
   American Samoa+1684
 * 
   Andorra+376
 * 
   Angola+244
 * 
   Anguilla+1264
 * 
   Antigua and Barbuda+1268
 * 
   Argentina+54
 * 
   Armenia (Հայաստան)+374
 * 
   Aruba+297
 * 
   Australia+61
 * 
   Austria (Österreich)+43
 * 
   Azerbaijan (Azərbaycan)+994
 * 
   Bahamas+1242
 * 
   Bahrain (‫البحرين‬‎)+973
 * 
   Bangladesh (বাংলাদেশ)+880
 * 
   Barbados+1246
 * 
   Belarus (Беларусь)+375
 * 
   Belgium (België)+32
 * 
   Belize+501
 * 
   Benin (Bénin)+229
 * 
   Bermuda+1441
 * 
   Bhutan (འབྲུག)+975
 * 
   Bolivia+591
 * 
   Bosnia and Herzegovina (Босна и Херцеговина)+387
 * 
   Botswana+267
 * 
   Brazil (Brasil)+55
 * 
   British Indian Ocean Territory+246
 * 
   British Virgin Islands+1284
 * 
   Brunei+673
 * 
   Bulgaria (България)+359
 * 
   Burkina Faso+226
 * 
   Burundi (Uburundi)+257
 * 
   Cambodia (កម្ពុជា)+855
 * 
   Cameroon (Cameroun)+237
 * 
   Canada+1
 * 
   Cape Verde (Kabu Verdi)+238
 * 
   Caribbean Netherlands+599
 * 
   Cayman Islands+1345
 * 
   Central African Republic (République centrafricaine)+236
 * 
   Chad (Tchad)+235
 * 
   Chile+56
 * 
   China (中国)+86
 * 
   Christmas Island+61
 * 
   Cocos (Keeling) Islands+61
 * 
   Colombia+57
 * 
   Comoros (‫جزر القمر‬‎)+269
 * 
   Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
 * 
   Congo (Republic) (Congo-Brazzaville)+242
 * 
   Cook Islands+682
 * 
   Costa Rica+506
 * 
   Côte d’Ivoire+225
 * 
   Croatia (Hrvatska)+385
 * 
   Cuba+53
 * 
   Curaçao+599
 * 
   Cyprus (Κύπρος)+357
 * 
   Czech Republic (Česká republika)+420
 * 
   Denmark (Danmark)+45
 * 
   Djibouti+253
 * 
   Dominica+1767
 * 
   Dominican Republic (República Dominicana)+1
 * 
   Ecuador+593
 * 
   Egypt (‫مصر‬‎)+20
 * 
   El Salvador+503
 * 
   Equatorial Guinea (Guinea Ecuatorial)+240
 * 
   Eritrea+291
 * 
   Estonia (Eesti)+372
 * 
   Ethiopia+251
 * 
   Falkland Islands (Islas Malvinas)+500
 * 
   Faroe Islands (Føroyar)+298
 * 
   Fiji+679
 * 
   Finland (Suomi)+358
 * 
   France+33
 * 
   French Guiana (Guyane française)+594
 * 
   French Polynesia (Polynésie française)+689
 * 
   Gabon+241
 * 
   Gambia+220
 * 
   Georgia (საქართველო)+995
 * 
   Germany (Deutschland)+49
 * 
   Ghana (Gaana)+233
 * 
   Gibraltar+350
 * 
   Greece (Ελλάδα)+30
 * 
   Greenland (Kalaallit Nunaat)+299
 * 
   Grenada+1473
 * 
   Guadeloupe+590
 * 
   Guam+1671
 * 
   Guatemala+502
 * 
   Guernsey+44
 * 
   Guinea (Guinée)+224
 * 
   Guinea-Bissau (Guiné Bissau)+245
 * 
   Guyana+592
 * 
   Haiti+509
 * 
   Honduras+504
 * 
   Hong Kong (香港)+852
 * 
   Hungary (Magyarország)+36
 * 
   Iceland (Ísland)+354
 * 
   India (भारत)+91
 * 
   Indonesia+62
 * 
   Iran (‫ایران‬‎)+98
 * 
   Iraq (‫العراق‬‎)+964
 * 
   Ireland+353
 * 
   Isle of Man+44
 * 
   Israel (‫ישראל‬‎)+972
 * 
   Italy (Italia)+39
 * 
   Jamaica+1
 * 
   Japan (日本)+81
 * 
   Jersey+44
 * 
   Jordan (‫الأردن‬‎)+962
 * 
   Kazakhstan (Казахстан)+7
 * 
   Kenya+254
 * 
   Kiribati+686
 * 
   Kosovo+383
 * 
   Kuwait (‫الكويت‬‎)+965
 * 
   Kyrgyzstan (Кыргызстан)+996
 * 
   Laos (ລາວ)+856
 * 
   Latvia (Latvija)+371
 * 
   Lebanon (‫لبنان‬‎)+961
 * 
   Lesotho+266
 * 
   Liberia+231
 * 
   Libya (‫ليبيا‬‎)+218
 * 
   Liechtenstein+423
 * 
   Lithuania (Lietuva)+370
 * 
   Luxembourg+352
 * 
   Macau (澳門)+853
 * 
   Macedonia (FYROM) (Македонија)+389
 * 
   Madagascar (Madagasikara)+261
 * 
   Malawi+265
 * 
   Malaysia+60
 * 
   Maldives+960
 * 
   Mali+223
 * 
   Malta+356
 * 
   Marshall Islands+692
 * 
   Martinique+596
 * 
   Mauritania (‫موريتانيا‬‎)+222
 * 
   Mauritius (Moris)+230
 * 
   Mayotte+262
 * 
   Mexico (México)+52
 * 
   Micronesia+691
 * 
   Moldova (Republica Moldova)+373
 * 
   Monaco+377
 * 
   Mongolia (Монгол)+976
 * 
   Montenegro (Crna Gora)+382
 * 
   Montserrat+1664
 * 
   Morocco (‫المغرب‬‎)+212
 * 
   Mozambique (Moçambique)+258
 * 
   Myanmar (Burma) (မြန်မာ)+95
 * 
   Namibia (Namibië)+264
 * 
   Nauru+674
 * 
   Nepal (नेपाल)+977
 * 
   Netherlands (Nederland)+31
 * 
   New Caledonia (Nouvelle-Calédonie)+687
 * 
   New Zealand+64
 * 
   Nicaragua+505
 * 
   Niger (Nijar)+227
 * 
   Nigeria+234
 * 
   Niue+683
 * 
   Norfolk Island+672
 * 
   North Korea (조선 민주주의 인민 공화국)+850
 * 
   Northern Mariana Islands+1670
 * 
   Norway (Norge)+47
 * 
   Oman (‫عُمان‬‎)+968
 * 
   Pakistan (‫پاکستان‬‎)+92
 * 
   Palau+680
 * 
   Palestine (‫فلسطين‬‎)+970
 * 
   Panama (Panamá)+507
 * 
   Papua New Guinea+675
 * 
   Paraguay+595
 * 
   Peru (Perú)+51
 * 
   Philippines+63
 * 
   Poland (Polska)+48
 * 
   Portugal+351
 * 
   Puerto Rico+1
 * 
   Qatar (‫قطر‬‎)+974
 * 
   Réunion (La Réunion)+262
 * 
   Romania (România)+40
 * 
   Russia (Россия)+7
 * 
   Rwanda+250
 * 
   Saint Barthélemy+590
 * 
   Saint Helena+290
 * 
   Saint Kitts and Nevis+1869
 * 
   Saint Lucia+1758
 * 
   Saint Martin (Saint-Martin (partie française))+590
 * 
   Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
 * 
   Saint Vincent and the Grenadines+1784
 * 
   Samoa+685
 * 
   San Marino+378
 * 
   São Tomé and Príncipe (São Tomé e Príncipe)+239
 * 
   Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
 * 
   Senegal (Sénégal)+221
 * 
   Serbia (Србија)+381
 * 
   Seychelles+248
 * 
   Sierra Leone+232
 * 
   Singapore+65
 * 
   Sint Maarten+1721
 * 
   Slovakia (Slovensko)+421
 * 
   Slovenia (Slovenija)+386
 * 
   Solomon Islands+677
 * 
   Somalia (Soomaaliya)+252
 * 
   South Africa+27
 * 
   South Korea (대한민국)+82
 * 
   South Sudan (‫جنوب السودان‬‎)+211
 * 
   Spain (España)+34
 * 
   Sri Lanka (ශ්‍රී ලංකාව)+94
 * 
   Sudan (‫السودان‬‎)+249
 * 
   Suriname+597
 * 
   Svalbard and Jan Mayen+47
 * 
   Swaziland+268
 * 
   Sweden (Sverige)+46
 * 
   Switzerland (Schweiz)+41
 * 
   Syria (‫سوريا‬‎)+963
 * 
   Taiwan (台灣)+886
 * 
   Tajikistan+992
 * 
   Tanzania+255
 * 
   Thailand (ไทย)+66
 * 
   Timor-Leste+670
 * 
   Togo+228
 * 
   Tokelau+690
 * 
   Tonga+676
 * 
   Trinidad and Tobago+1868
 * 
   Tunisia (‫تونس‬‎)+216
 * 
   Turkey (Türkiye)+90
 * 
   Turkmenistan+993
 * 
   Turks and Caicos Islands+1649
 * 
   Tuvalu+688
 * 
   U.S. Virgin Islands+1340
 * 
   Uganda+256
 * 
   Ukraine (Україна)+380
 * 
   United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
 * 
   United Kingdom+44
 * 
   United States+1
 * 
   Uruguay+598
 * 
   Uzbekistan (Oʻzbekiston)+998
 * 
   Vanuatu+678
 * 
   Vatican City (Città del Vaticano)+39
 * 
   Venezuela+58
 * 
   Vietnam (Việt Nam)+84
 * 
   Wallis and Futuna (Wallis-et-Futuna)+681
 * 
   Western Sahara (‫الصحراء الغربية‬‎)+212
 * 
   Yemen (‫اليمن‬‎)+967
 * 
   Zambia+260
 * 
   Zimbabwe+263
 * 
   Åland Islands+358


DOWNLOAD
This form collects your details so that we can send you updates about our
products and services by email. Read our Privacy Policy to see how we manage and
protect our data.
BESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswy